At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TMDX TransMedics Group, Inc.
Closed Memorial Day 05-24 16:00:00 EDT
140.29
+2.76
+2.01%
盘后140.39
+0.10+0.07%
19:56 EDT
High142.78
Low137.25
Vol584.98K
Open137.91
D1 Closing137.53
Amplitude4.02%
Mkt Cap4.62B
Tradable Cap4.48B
Total Shares32.94M
T/O82.46M
T/O Rate1.83%
Tradable Shares31.92M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Fresenius Medical Care AG & Co. KGaA (GB:0H9X) and CompuGroup Medical (GB:0MSD)
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.